vs
Side-by-side financial comparison of Phathom Pharmaceuticals, Inc. (PHAT) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $57.6M, roughly 1.6× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -1.5%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-167.0M).
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
PHAT vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.6M | $93.5M |
| Net Profit | — | $3.0M |
| Gross Margin | 86.7% | 41.0% |
| Operating Margin | — | 7.0% |
| Net Margin | — | 3.2% |
| Revenue YoY | 94.1% | -1.5% |
| Net Profit YoY | 71.6% | -3.7% |
| EPS (diluted) | — | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.6M | $93.5M | ||
| Q3 25 | $49.5M | $88.9M | ||
| Q2 25 | $39.5M | $89.4M | ||
| Q1 25 | $28.5M | $85.7M | ||
| Q4 24 | $29.7M | $94.9M | ||
| Q3 24 | $16.4M | $88.5M | ||
| Q2 24 | $7.3M | $85.8M | ||
| Q1 24 | — | $86.8M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-30.0M | $453.0K | ||
| Q2 25 | $-75.8M | $-9.5M | ||
| Q1 25 | $-94.3M | $-4.0M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $-85.6M | $-60.6M | ||
| Q2 24 | $-91.4M | $-1.7M | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | 86.7% | 41.0% | ||
| Q3 25 | 87.5% | 40.6% | ||
| Q2 25 | 87.2% | 40.6% | ||
| Q1 25 | 86.9% | 39.6% | ||
| Q4 24 | 87.1% | 42.4% | ||
| Q3 24 | 85.6% | 41.2% | ||
| Q2 24 | 81.2% | 39.5% | ||
| Q1 24 | — | 42.3% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | -30.8% | 1.9% | ||
| Q2 25 | -151.7% | -1.9% | ||
| Q1 25 | -276.5% | -2.4% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | -433.0% | -67.4% | ||
| Q2 24 | -1055.4% | -2.2% | ||
| Q1 24 | — | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | -60.5% | 0.5% | ||
| Q2 25 | -191.9% | -10.6% | ||
| Q1 25 | -330.7% | -4.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | -523.3% | -68.5% | ||
| Q2 24 | -1248.6% | -2.0% | ||
| Q1 24 | — | -1.2% |
| Q4 25 | — | $9.50 | ||
| Q3 25 | $-0.41 | $-0.86 | ||
| Q2 25 | $-1.05 | $-2.73 | ||
| Q1 25 | $-1.31 | $-1.66 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | $-1.32 | $-12.79 | ||
| Q2 24 | $-1.56 | $-1.19 | ||
| Q1 24 | — | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $130.0M | $23.6M |
| Total DebtLower is stronger | $209.1M | $41.5M |
| Stockholders' EquityBook value | $-438.2M | $111.4M |
| Total Assets | $259.1M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.0M | $23.6M | ||
| Q3 25 | $135.2M | $26.7M | ||
| Q2 25 | $149.6M | $26.0M | ||
| Q1 25 | $212.3M | $31.0M | ||
| Q4 24 | $297.3M | $29.9M | ||
| Q3 24 | $334.7M | $20.0M | ||
| Q2 24 | $276.2M | $14.7M | ||
| Q1 24 | — | $18.7M |
| Q4 25 | $209.1M | $41.5M | ||
| Q3 25 | $207.1M | $41.4M | ||
| Q2 25 | $205.1M | $41.3M | ||
| Q1 25 | $203.2M | $41.3M | ||
| Q4 24 | $201.4M | $41.2M | ||
| Q3 24 | $175.7M | — | ||
| Q2 24 | $174.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $-438.2M | $111.4M | ||
| Q3 25 | $-422.5M | $-26.3M | ||
| Q2 25 | $-405.8M | $-21.7M | ||
| Q1 25 | $-338.4M | $-13.5M | ||
| Q4 24 | $-253.6M | $-8.3M | ||
| Q3 24 | $-187.1M | $-2.7M | ||
| Q2 24 | $-233.8M | $45.8M | ||
| Q1 24 | — | $51.4M |
| Q4 25 | $259.1M | $407.7M | ||
| Q3 25 | $240.3M | $406.9M | ||
| Q2 25 | $250.2M | $415.9M | ||
| Q1 25 | $294.2M | $421.5M | ||
| Q4 24 | $378.3M | $430.2M | ||
| Q3 24 | $387.0M | $412.5M | ||
| Q2 24 | $319.4M | $474.1M | ||
| Q1 24 | — | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.8M | $3.2M |
| Free Cash FlowOCF − Capex | $-167.0M | $2.9M |
| FCF MarginFCF / Revenue | -290.0% | 3.1% |
| Capex IntensityCapex / Revenue | 0.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $-328.9M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.8M | $3.2M | ||
| Q3 25 | $-14.1M | $9.5M | ||
| Q2 25 | $-62.7M | $932.0K | ||
| Q1 25 | $-84.9M | $9.1M | ||
| Q4 24 | $-266.8M | $-10.0M | ||
| Q3 24 | $-63.6M | $12.5M | ||
| Q2 24 | $-70.7M | $8.7M | ||
| Q1 24 | — | $6.9M |
| Q4 25 | $-167.0M | $2.9M | ||
| Q3 25 | $-14.1M | $9.4M | ||
| Q2 25 | $-62.8M | $787.0K | ||
| Q1 25 | $-84.9M | $8.7M | ||
| Q4 24 | $-266.9M | $-10.3M | ||
| Q3 24 | $-63.6M | $12.4M | ||
| Q2 24 | $-70.8M | $8.5M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | -290.0% | 3.1% | ||
| Q3 25 | -28.6% | 10.5% | ||
| Q2 25 | -159.0% | 0.9% | ||
| Q1 25 | -297.9% | 10.1% | ||
| Q4 24 | -899.8% | -10.8% | ||
| Q3 24 | -389.0% | 14.0% | ||
| Q2 24 | -966.2% | 10.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.2% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.5% | 0.2% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.6% | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PHAT
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
